racotumomab (TAB-H58)

Anti-Human NGcGM3 Recombinant Antibody (Vaxira) TAB-H58 1mg Please Inquiry


  • Product Overview
  • Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
  • CAS
  • 946832-34-4
  • Trade name
  • vaxira
  • Specific Activity
  • idiotope of anti-(N-glycolylneuraminic acid (NeuGc, NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 [Homo sapiens]
  • Protein Construction
  • "Racotumomab (1E10) antibody reacts to the idiotype (the term idiotype refers to the recognition zone in antibodies) of another antibodyknown as P3. Now P3 is quite specific for the recognition of N-glycolyl ceramides of Mono-sialyl Lactose."
  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.


  • Introduction
  • The tumor antigen N-glycolil (NGc) GM3 (NGcGM3), a type of ganglioside present on the cell surface of malignant cells from lung and breast, melanoma, as well as neuroectodermal pediatric tumors
  • Keywords
  • N-glycolil (NGc) GM3; NGcGM3; NGNA ganglioside

Related Products

All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.

Online Inquiry

Verification code
Click image to refresh the verification code.


USA: 45-1 Ramsey Road, Shirley, NY 11967, USA
Europe: Heidenkampsweg 58, 20097 Hamburg, Germany
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us